Tislelizumab trials for Extensive-stage Small-cell Lung Cancer

All Tislelizumab trials · All Extensive-stage Small-cell Lung Cancer trials

Phase breakdown

Recruiting trials studying Tislelizumab for Extensive-stage Small-cell Lung Cancer

• A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing Chemotherapy Combined With Tislelizumab as First-line Treatment in Patients With Extensive-stage Small Cell Lung Cancer(PANKU-Lung07)
  NCT07502300 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
  NCT07652736 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
  NCT06536868 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 6 locations

Common questions

How many trials study Tislelizumab for Extensive-stage Small-cell Lung Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.